The global dietary supplements market was valued at USD 86.77 billion in 2023 and is forecasted to grow from USD 93.46 billion in 2024 to USD 182.52 billion by 2032, reflecting a CAGR of 8.73% during 2024–2032. In 2023, Asia Pacific accounted for the largest market share at 41.97%.
Dietary supplements, which are consumed orally and contain one or more nutritional ingredients, are witnessing rising demand. Growth is being driven by increasing interest in sports nutrition and performance-enhancing products, coupled with greater consumer awareness of daily micronutrient requirements. Higher spending on health and wellness products also contributes to market expansion.
Government support for herbal supplements is further propelling growth. For instance, in March 2021, India’s Ministry of AYUSH launched the Centrally Sponsored National AYUSH Mission (NAM), offering subsidies of 30%, 50%, and 75% for cultivating nearly 140 varieties of medicinal and herbal plants.
Although the COVID-19 pandemic initially disrupted supply chains and trade, it ultimately boosted demand for dietary supplements worldwide, as consumers turned to these products for immunity strengthening and overall health protection.
Information Source: https://www.fortunebusinessinsights.com/dietary-supplements-market-102082
Segmentation Insights
The market is segmented by type, with vitamins leading the category due to their essential role in preventing deficiencies and supporting overall health. By form, tablets dominate, favored for their stability, affordability, and ease of storage and transport. In terms of application, general health supplements hold the largest share, supported by the growing trend of preventive healthcare. By end user, adults account for the biggest segment, driven by rising fitness awareness and healthier lifestyle choices. By distribution channel, pharmacies remain the leading outlet, as many consumers prefer professional guidance before purchase.
Market Drivers and Challenges
The shift toward preventive healthcare, particularly among aging populations and individuals with chronic illnesses, is a major growth driver. Continuous innovation from both established players and emerging brands is widening product availability. However, high product costs remain a barrier in price-sensitive regions, restricting adoption.
Regional Outlook
Asia Pacific is expected to maintain its leadership position, expanding at a CAGR of 8.50% through 2032, supported by growing health consciousness and increased spending on nutrition. North America is also showing steady growth, largely influenced by the high prevalence of chronic conditions such as diabetes and obesity.
Competitive Landscape
Industry leaders are focusing on innovation, portfolio diversification, and international expansion. Scaling production capabilities and implementing targeted marketing strategies are helping companies strengthen their market presence. For example, Nestlé S.A. continues to expand its product range and enhance its global footprint to capture rising demand.
Key Companies Profiled
- Amway Corp (U.S.)
- Abbott (U.S.)
- Nestlé S.A. (Switzerland)
- Herbalife Nutrition Ltd. (U.S.)
- Archer Daniels Midland Company (U.S.)
- Glanbia Nutritionals (U.S.)
- Otsuka Holdings Co. Ltd. (Japan)
- Arkopharma (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dietary-supplements-market-102082
Recent Development
- November 2023: Abbott launched an improved version of its PediaSure supplement, featuring the proprietary Nutri-Pull system. The updated formula includes essential nutrients such as vitamins C, D, and K2, along with casein phosphopeptides (CPPs), to better support children’s growth and nutritional needs.
